Edition:
United Kingdom

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

3.01USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$3.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,394
52-wk High
$10.25
52-wk Low
$1.92

Chart for

About

Leap Therapeutics, Inc., formerly HealthCare Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company engages in acquiring and developing therapeutics in cancer biology. Its lead product candidates for use in clinical trials include TRX518 and DKN-01. DKN-01 is a monoclonal antibody targeting Dickkopf-re... (more)

Overall

Beta: --
Market Cap(Mil.): $50.10
Shares Outstanding(Mil.): 9.40
Dividend: --
Yield (%): --

Financials

  LPTX.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -3.51 -- --
ROI: -4,400.15 8.99 14.48
ROE: -- 10.13 15.99

Earnings vs. Estimates